Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will evaluate the pharmacokinetic profiles of experimental formulations of paracetamol.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental paracetamol formulation | Experimental | Experimental formulation |
|
| Marketed paracetamol | Active Comparator | Marketed formulation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Marketed paracetamol | Drug | marketed formulation |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Bioavailability as measured by Area Under the Curve (AUC) in both fasted and fed state | baseline to 12 hours | |
| Effect of food on the extent and rate of paracetamol absorption as measured by AUC and Cmax | baseline to 12 hours |
| Measure | Description | Time Frame |
|---|---|---|
| To assess descriptive pharmaokinetic characteristics (Tmax, T1/2, Cmax, AUC) | baseline to 12 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| MDS Pharma Services NEBRASKA | Lincoln | Nebraska | 68501 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Experimental paracetamol formulation |
| Drug |
Experimental formulation |
|